Tag: including-dronabinol

Commercial & Investment Banking Picture Gallery

RespireRx Pharmaceuticals Inc. to Present at the 2017 Marcum MicroCap Conference

June 14, 2017
Presse

CEO to review: dronabinol, a Phase 3-ready medicine for the treatment of obstructive sleep apnea; and…

Continue Reading